12. Subsequent Events

On July 7, 2026, the Company completed its previously announced acquisition (the “Robocath Acquisition”) of shares and other securities collectively representing 100% of the share capital and voting power of Robocath, a French société par actions simplifiée (“Robocath”), pursuant to the Share Sale Agreement dated April 14, 2026, for upfront consideration of approximately $20.0 million in cash and common stock.

Robocath, headquartered in Rouen, France, is an innovator of advanced mechanical robotic technology for interventional cardiology and neurointerventions.

At the closing of the Robocath Acquisition, the Company made certain cash payments of $2.7 million for the benefit of Robocath’s securityholders and issued (i) 1,469,485 shares of common stock and (ii) pre-funded warrants to purchase 4,575,143 shares of common stock to the securityholders. The Company also issued 225,000 shares of common stock to Robocath’s financial advisor as partial payment of a success fee for acquisition advisory services. Additionally, an aggregate of $1.1 million of interim financing provided to Robocath was settled as a reduction to the upfront consideration paid at the closing. The Share Sale Agreement provides for up to $25.0 million of additional earnout consideration, payable in cash, shares of common stock (including shares issuable upon exercise of Purchaser Warrants) or a combination thereof at the Company’s election, upon achievement of one regulatory milestone and two commercial milestones during periods ending December 31, 2033, December 31, 2035 and December 31, 2037, respectively. In no event will the Company be obligated to issue a number of earnout shares, that, together with the Upfront Stock Consideration, warrants, and payments to Robocath’s financial advisor, would exceed 19.9% of the total number of shares of the Company’s common stock issued and outstanding immediately prior to the July 7, 2026 closing. Because the Robocath Acquisition occurred after June 30, 2026, the initial accounting for the business combination, including the purchase price allocation and the estimated fair value of contingent consideration, has not been completed. The results of Robocath will be included in the Company’s consolidated financial statements beginning July 7, 2026.